 |  |
| ABX | ||
| 2,929.414 | ||
| 59.7580 | 0.0208% | |
| BISNIS-27 | ||
| 436.311 | ||
| 0.0460 | 0.0001% | |
| DBX | ||
| 2,891.228 | ||
| -44.6100 | -0.0152% | |
| ECONOMIC30 | ||
| 87.326 | ||
| -0.1640 | -0.0019% | |
| ESGQKEHATI | ||
| 103.160 | ||
| -0.2200 | -0.0021% | |
| ESGSKEHATI | ||
| 104.258 | ||
| -0.1750 | -0.0017% | |
| I-GRADE | ||
| 157.331 | ||
| -0.7210 | -0.0046% | |
| AUDRP | ||
| 12,523.060 | ||
| 11.6400 | 0.0930% | |
| EURRP | ||
| 20,578.060 | ||
| 23.0800 | 0.1123% | |
| JPYRP | ||
| 110.655 | ||
| 0.3083 | 0.2794% | |
| SINRP | ||
| 13,827.310 | ||
| 20.8700 | 0.1512% | |
| USDRP | ||
| 17,728.000 | ||
| 24.0000 | 0.1356% | |
Sejumlah lembaga asal Indonesia bekerja sama dengan perusahaan farmasi luar negeri dalam mengembangkan produksi vaksin COVID-19 di dalam negeri. Badan Pengawas Obat dan Makanan (BPOM) mencatat setidaknya terdapat lima pengembangan kandidat vaksin COVID-19 yang cukup menjanjikan.
